>> New Advances in Chemotherapy: 'The Proof May be in the Sugar' Says Researchers [sic]
Source: Pro-Pharmaceuticals December 18, 2003
…“Once the results of the Phase l human trials are reported to the Food and Drug Administration, the FDA will decide whether DAVANAT-1 should be added to the arsenal of cancer fighting drugs.” <<
LMAO—when was the last time the FDA approved a drug based on phase-1 data?
I do have to give PRW some credit, however: it’s now five years later and they’ve advanced to phase-2. So they’re making some headway
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”